Literature DB >> 24535498

The bone kidney axis.

Michel Baum1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24535498      PMCID： PMC4074396          DOI： 10.1097/MOP.0000000000000071

Source DB:  PubMed          Journal:  Curr Opin Pediatr        ISSN： 1040-8703            Impact factor:   2.856


× No keyword cloud information.
  9 in total

1.  FGF23 induces left ventricular hypertrophy.

Authors:  Christian Faul; Ansel P Amaral; Behzad Oskouei; Ming-Chang Hu; Alexis Sloan; Tamara Isakova; Orlando M Gutiérrez; Robier Aguillon-Prada; Joy Lincoln; Joshua M Hare; Peter Mundel; Azorides Morales; Julia Scialla; Michael Fischer; Elsayed Z Soliman; Jing Chen; Alan S Go; Sylvia E Rosas; Lisa Nessel; Raymond R Townsend; Harold I Feldman; Martin St John Sutton; Akinlolu Ojo; Crystal Gadegbeku; Giovana Seno Di Marco; Stefan Reuter; Dominik Kentrup; Klaus Tiemann; Marcus Brand; Joseph A Hill; Orson W Moe; Makoto Kuro-O; John W Kusek; Martin G Keane; Myles Wolf
Journal:  J Clin Invest       Date:  2011-10-10       Impact factor: 14.808

2.  Early skeletal and biochemical alterations in pediatric chronic kidney disease.

Authors:  Katherine Wesseling-Perry; Renata C Pereira; Chi-Hong Tseng; Robert Elashoff; Joshua J Zaritsky; Ora Yadin; Shobha Sahney; Barbara Gales; Harald Jüppner; Isidro B Salusky
Journal:  Clin J Am Soc Nephrol       Date:  2011-11-03       Impact factor: 8.237

Review 3.  Phosphate is a vascular toxin.

Authors:  Rukshana Shroff
Journal:  Pediatr Nephrol       Date:  2012-11-17       Impact factor: 3.714

Review 4.  Regulation of phosphate transport by fibroblast growth factor 23 (FGF23): implications for disorders of phosphate metabolism.

Authors:  Jyothsna Gattineni; Michel Baum
Journal:  Pediatr Nephrol       Date:  2009-08-11       Impact factor: 3.714

5.  Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis.

Authors:  W G Goodman; J Goldin; B D Kuizon; C Yoon; B Gales; D Sider; Y Wang; J Chung; A Emerick; L Greaser; R M Elashoff; I B Salusky
Journal:  N Engl J Med       Date:  2000-05-18       Impact factor: 91.245

6.  Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease.

Authors:  Tamara Isakova; Patricia Wahl; Gabriela S Vargas; Orlando M Gutiérrez; Julia Scialla; Huiliang Xie; Dina Appleby; Lisa Nessel; Keith Bellovich; Jing Chen; Lee Hamm; Crystal Gadegbeku; Edward Horwitz; Raymond R Townsend; Cheryl A M Anderson; James P Lash; Chi-Yuan Hsu; Mary B Leonard; Myles Wolf
Journal:  Kidney Int       Date:  2011-03-09       Impact factor: 10.612

Review 7.  Fibroblast growth factor 23 and adverse clinical outcomes in chronic kidney disease.

Authors:  Tamara Isakova
Journal:  Curr Opin Nephrol Hypertens       Date:  2012-05       Impact factor: 2.894

8.  Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis.

Authors:  Orlando M Gutiérrez; Michael Mannstadt; Tamara Isakova; Jose Alejandro Rauh-Hain; Hector Tamez; Anand Shah; Kelsey Smith; Hang Lee; Ravi Thadhani; Harald Jüppner; Myles Wolf
Journal:  N Engl J Med       Date:  2008-08-07       Impact factor: 91.245

Review 9.  Phosphate homeostasis and its role in bone health.

Authors:  Maria Goretti Penido; Uri S Alon
Journal:  Pediatr Nephrol       Date:  2012-05-03       Impact factor: 3.714
  9 in total
  1 in total

1.  Surgical Treatment for Parathyroid Adenoma: A Case Report.

Authors:  Prihantono Prihantono; Emmy Palinggi; Haryasena Haryasena; William Hamdani; I Made Christian Binekada
Journal:  Open Access Maced J Med Sci       Date:  2019-08-13
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.